UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists

Nature structural & molecular biology, 2017-10, Vol.24 (10), p.848

2017

Volltextzugriff (PDF)

Somatic mutations lead to an oncogenic deletion of met in lung cancer

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.283-289

2006

Volltextzugriff (PDF)

The Sema domain of Met is necessary for receptor dimerization and activation

Cancer cell, 2004-07, Vol.6 (1), p.75-84

2004

Volltextzugriff (PDF)

Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

BMC medical genetics, 2018-02, Vol.19 (1), p.22-22, Article 22

2018

Volltextzugriff (PDF)

Met Activation and Receptor Dimerization in Cancer: A Role for the Sema Domain

Cell cycle (Georgetown, Tex.), 2005-05, Vol.4 (5), p.683-685

2005

Volltextzugriff (PDF)

The tumor suppressor tuberin regulates mitotic onset through the cellular localization of cyclin B1

Cell cycle (Georgetown, Tex.), 2011-09, Vol.10 (18), p.3129-3139

2011

Volltextzugriff (PDF)

Interaction of Fibroblast Growth Factor Receptor 3 and the Adapter Protein SH2-B

The Journal of biological chemistry, 2002-05, Vol.277 (18), p.15962-15970

2002

Volltextzugriff (PDF)

Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor

The Journal of biological chemistry, 2014-01, Vol.289 (2), p.942-955

2014

Volltextzugriff (PDF)

Patched1 interacts with cyclin B1 to regulate cell cycle progression

The EMBO journal, 2001-05, Vol.20 (9), p.2214-2223

2001

Volltextzugriff (PDF)

Human Speedy

The Journal of cell biology, 2002-04, Vol.157 (3), p.357-366

2002

Volltextzugriff (PDF)

Design of Organo-Peptides As Bipartite PCSK9 Antagonists

ACS chemical biology, 2020-02, Vol.15 (2), p.425-436

2020

Volltextzugriff (PDF)

Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels

The Journal of biological chemistry, 2012-12, Vol.287 (52), p.43482-43491

2012

Volltextzugriff (PDF)

Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction

The EMBO journal, 2000-03, Vol.19 (6), p.1378-1388

2000

Volltextzugriff (PDF)

Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation

The Journal of biological chemistry, 2002-05, Vol.277 (18), p.15962-15970

2002

Volltextzugriff (PDF)

Calcium-Independent Inhibition of PCSK9 by Affinity-Improved Variants of the LDL Receptor EGF(A) Domain

Journal of molecular biology, 2012-10, Vol.422 (5), p.685-696

2012

Volltextzugriff (PDF)

Human Speedy: A Novel Cell Cycle Regulator That Enhances Proliferation through Activation of Cdk2

The Journal of cell biology, 2002-04, Vol.157 (3), p.357-366

2002

Volltextzugriff (PDF)

Spy1 Interacts with p27 Kip1 to Allow G 1 /S Progression

Molecular biology of the cell, 2003-09, Vol.14 (9), p.3664-3674

2003

Volltextzugriff (PDF)

Umasking large and persistent reductions in proliferation rate of aging cells

In vitro cellular & developmental biology. Animal, 1997-12, Vol.33 (10), p.809-818

1997

Volltextzugriff (PDF)

Novel interactions of the cell cycle and cell signaling identified by two -hybrid screens

Beltran, Monica Kong

2002

Volltextzugriff (PDF)

Spy1 interacts with p27Kip1 to allow G1/S progression

Molecular biology of the cell, 2003-09, Vol.14 (9), p.3664-3674

2003

Volltextzugriff (PDF)

Unmasking Large and Persistent Reductions in Proliferation Rate of Aging Cells

In vitro cellular & developmental biology. Animal, 1997-11, Vol.33 (10), p.809-818

1997

Volltextzugriff (PDF)

Chapter 264 - Signaling from FGF Receptors in Development and Disease

Handbook of Cell Signaling, 2003, p.861-865

2003

Volltextzugriff (PDF)

Persistent metabolic adaptation 6 years after “The Biggest Loser” competition

Obesity (Silver Spring, Md.), 2016-08, Vol.24 (8), p.1612-1619

2016

Volltextzugriff (PDF)

Regulation and Directing Stem Cell Fate by Tissue Engineering Functional Microenvironments: Scaffold Physical and Chemical Cues

Stem cells international, 2019, Vol.2019, p.2180925-16

2019

Volltextzugriff (PDF)

Calorie for Calorie, Dietary Fat Restriction Results in More Body Fat Loss than Carbohydrate Restriction in People with Obesity

Cell metabolism, 2015-09, Vol.22 (3), p.427-436

2015

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists

Somatic mutations lead to an oncogenic deletion of met in lung cancer

The Sema domain of Met is necessary for receptor dimerization and activation

Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

Met Activation and Receptor Dimerization in Cancer: A Role for the Sema Domain

The tumor suppressor tuberin regulates mitotic onset through the cellular localization of cyclin B1

Interaction of Fibroblast Growth Factor Receptor 3 and the Adapter Protein SH2-B

Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor

Patched1 interacts with cyclin B1 to regulate cell cycle progression

Human Speedy

Design of Organo-Peptides As Bipartite PCSK9 Antagonists

Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels

Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction

Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation

Calcium-Independent Inhibition of PCSK9 by Affinity-Improved Variants of the LDL Receptor EGF(A) Domain

Human Speedy: A Novel Cell Cycle Regulator That Enhances Proliferation through Activation of Cdk2

Spy1 Interacts with p27 Kip1 to Allow G 1 /S Progression

Umasking large and persistent reductions in proliferation rate of aging cells

Novel interactions of the cell cycle and cell signaling identified by two -hybrid screens

Spy1 interacts with p27Kip1 to allow G1/S progression

Unmasking Large and Persistent Reductions in Proliferation Rate of Aging Cells

Chapter 264 - Signaling from FGF Receptors in Development and Disease

Persistent metabolic adaptation 6 years after “The Biggest Loser” competition

Regulation and Directing Stem Cell Fate by Tissue Engineering Functional Microenvironments: Scaffold Physical and Chemical Cues

Calorie for Calorie, Dietary Fat Restriction Results in More Body Fat Loss than Carbohydrate Restriction in People with Obesity

Suchergebnisse filtern